Schedule 13D ownership disclosure
Invivyd Inc
Common Stock, $0.0001 par value per share · CUSIP: 00534A102
Event date: 2025-11-17
- Filing-level shares
- 20,454,490
- Percent of class
- 8.8%
- Adimab, LLCReported CIK 0001545672
Shares: 20,454,490 · Class: 8.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-288171
- Form type
- SCHEDULE 13D/A
- Filer
- Adimab, LLC
- CIK
- CIK 1545672
- Filed
- Nov 19, 2025
- Reporting period
- Nov 17, 2025
- Description
- Schedule 13D beneficial ownership